Purchase Order 75F40121P00285
Award Date
6/24/21
Potential Completion Date
6/29/26
Potential Value
$76K
Federal Agency
Food and Drug Administration
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Winchester, MA 01890, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order, valued at $201,939.00, was awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance services on MiSeq benchtop sequencing instruments. The award does not have a set-aside designation. Illumina is a manufacturer of genetic sequencing systems and has a history of supporting genomic research and diagnostics across multiple federal agencies. This award indicates Illumina is providing maintenance services to help ensure the...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for the repair and maintenance of seven Illumina MiSeq instruments owned by the FDA's Center for Food Safety and Applied Nutrition (CFSAN). The contract includes a base period of performance through December 30, 2027, with four one-year option periods. The total ceiling value of the contract is $422,733.60. Illumina, a manufacturer of sequencing and genomic analysis instruments and...
This is a $58,464.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventive maintenance services on two (2) Illumina MiSeq instruments. The award has an ultimate completion date of July 19, 2027 and does not utilize any set-aside designations. Illumina is a manufacturer of genomic sequencing instruments and reagents, and has been awarded numerous past federal prime contracts and subcontracts across agencies such as the NIH, CDC, USDA,...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $89,573.00, is for preventative maintenance and repair services for the agency's MiSeq sequencing system. The contract has an ultimate completion date of April 30, 2028 and does not include any set-aside designation. Illumina has previously provided a range of sequencing instruments, reagents, and...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for $170,153.16 to provide annual on-site preventative maintenance service and unlimited repairs as needed on two Illumina MiSeq whole genome sequencers for a base year plus four option years. The contract has no set-aside designation. Based on Illumina's history as a prime contractor and subcontractor for sequencing systems and services across various federal agencies, this award aligns...
This firm fixed price purchase order for $70,930.76 was awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract is for preventive maintenance and repair services on Illumina's MiSeq sequencing system. This award does not have a set-aside designation. Through prior prime contract awards, Illumina has provided sequencing instruments, reagents, and related services to...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance and reagents for the company's MiSeq benchtop sequencer. The total ceiling value of the contract is $292,446.20, with a performance period ending on December 5, 2016. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has provided similar products and services to support genomic research and diagnostics for...
This firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to provide a diagnostic check and system upgrades for the MiSeq Whole Genome Sequencer at six FDA laboratories. The $84,733.20 contract has a completion date of December 31, 2022 and was sole-sourced to Illumina due to the proprietary nature of the MiSeq technology. Illumina has previously provided sequencing systems,...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for a MISEQ SERVICE AGREEMENT for two MiSeq sequencing instruments. The contract has a ceiling value of $160,610.22 and a period of performance through August 3, 2028. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has previously been awarded prime contracts and subcontracts by various federal agencies to...
This firm-fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for an ILLUMINA NOVASEQ 6000 SERVICE CONTRACT. The contract has a period of performance through September 26, 2029 and a ceiling value of $780,844.00. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents that have been used to support research and diagnostic efforts across federal agencies such as the NIH, CDC, USDA, and VA. This contract...